Skip to content

Clinical trials

Leukemia, Lymphocytic, Chronic, B-Cell trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Country / region: Taiwan Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20134
20141
20161
20173
20193
20204
20214
20221
20234
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting13
Completed8
Recruiting5
Terminated2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Janssen Research & Development, LLC5
AstraZeneca4
Loxo Oncology, Inc.4
Merck Sharp & Dohme LLC3
Acerta Pharma BV2
Gilead Sciences2
BeOne Medicines1
BeiGene1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell30
Lymphoma, Non-Hodgkin9
Lymphoma, B-Cell5
Hematologic Diseases4
Leukemia, B-Cell4
Neoplasms4
Lymphoma, Follicular3
Waldenstrom Macroglobulinemia3
Leukemia2
Leukemia, Myeloid, Acute2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.